Agamree可以在哪里买到

Agamree was developed by Santhera Pharmaceuticals in Switzerland. It is a glucocorticoid drug with anti-inflammatory and immunosuppressive effects. It is suitable for the treatment of patients with Duchenne muscular dystrophy (DMD) aged 2 years and above.

Where to buy Agamree

Agamree is not yet available in China. If you need to buy it, you can refer to the following channels.

Purchase overseas

Agamree has been launched in Germany, the United States, the United Kingdom and other countries. Patients can directly go to regular medical institutions or pharmacies in these countries to purchase it. A doctor's prescription, patient identification and diagnostic report are required when purchasing. Some countries may require patients to undergo a local medical evaluation.

Online purchase

Some online platforms make it easier to purchase Agamree. When choosing a platform, you need to verify whether it has legal qualifications. You should upload a prescription and fill in patient details before placing an order. The platform will usually arrange for professional pharmacists to review it. After receiving the medicine, you must immediately check the packaging seal, batch number and expiration date, and compare it with the original manufacturer's information.

Agamree is available in 100mL glass bottles, and the original Swiss price is approximately US$9,764 per box. Prices may change due to transportation costs or exchange rate fluctuations. It is recommended to compare prices through multiple channels before purchasing.

How to store Agamree

The correct storage method directly affects the pharmaceutical ingredients of Agamree. The following are the specific storage requirements.

Storage conditions of unopened medicines

Unopened Agamree must be stored upright in the original packaging at a room temperature of 20°C to 25°C. Temperature fluctuations of 15°C to 30°C are allowed for short periods of time. Avoid direct sunlight or close to heat sources such as radiators. If the ambient temperature exceeds 30°C, it is recommended to use an insulated box for temporary storage and transfer to a suitable environment as soon as possible.

Management and disposal after opening

After opening, the medicine bottle should be placed upright in the refrigerator at 2°C to 8°C. Do not freeze. The medicine must be returned to the refrigerator immediately after each withdrawal, and the bottle mouth must be tightened to prevent contamination. Unused medicinal solution within 3 months after opening the bottle must be discarded, and it cannot be used even if there is a large amount left.

If the liquid is found to be stratified, discolored, or has suspended solids, it indicates that the drug may have deteriorated and use should be stopped immediately.

Agamree Precautions

When using Agamree, you need to closely observe your body’s reaction. The following are precautions and suggestions.

Immunosuppression and infection prevention and control

Agamree may reduce immunity. Patients need to avoid going to crowded places to reduce exposure to sources of infectious diseases. If symptoms such as fever, persistent cough, or wound redness and swelling occur, you should seek medical treatment in time. It is not recommended to vaccinate with live vaccines during treatment, and routine vaccines need to be vaccinated 4-6 weeks before treatment.

Endocrine and Metabolic Monitoring

Long-term use of Agamree may lead to increased blood sugar, decreased bone density or suppression of adrenal function. Patients need to regularly check fasting blood sugar, bone density and blood calcium levels, and supplement vitamin D or calcium if necessary. If you have abnormal thirst, polyuria, or are prone to fractures, you need to contact your doctor immediately to adjust your treatment plan.

In daily care, DMD patients need to maintain moderate rehabilitation training, such as water exercise or stretching exercises, to delay muscle atrophy. The diet should be balanced and rich in protein. People with difficulty swallowing can choose nutritional paste. Regularly review cardiopulmonary function, joint mobility and eye conditions, and conduct a comprehensive health assessment every six months.